Molecular Targeting Technologies, Inc.
Biotechnology company · West Chester, Pennsylvania, United States
Molecular Targeting Technologies, Inc. is a biotechnology company headquartered in West Chester, Pennsylvania, United States. It has received 22 US government small-business research awards (SBIR/STTR) from health agencies, $11 million in total, most recently in 2023.
Molecular Targeting Technologies at a glance
What does Molecular Targeting Technologies do?
US government research funding
22 SBIR/STTR small-business research awards from US health agencies, $11.3 million in total (1995 to 2023). NIH funding came from the National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Heart, Lung, and Blood Institute.
Frequently asked questions about Molecular Targeting Technologies
Where is Molecular Targeting Technologies headquartered?
Molecular Targeting Technologies, Inc. is headquartered in West Chester, Pennsylvania, United States.
What does Molecular Targeting Technologies do?
Molecular Targeting Technologies, Inc. is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences